Epitalon (AEDG Peptide): Telomerase and Aging Research

# Epitalon (AEDG Peptide): The Pineal Tetrapeptide in Telomerase and Aging Research

Researchers can use our peptide comparison page to evaluate pricing and sourcing options.

Epitalon (also referred to as Epithalon or Epithalone) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG). Developed at the St. Petersburg Institute of Bioregulation and Gerontology, this compound is a synthetic analog of the naturally occurring pineal gland peptide preparation Epithalamin. Over the past 25 years, Epitalon has accumulated a substantial body of peer-reviewed research investigating its effects on telomerase activity [PMID 12937682], chromatin remodeling, melatonin synthesis, antioxidant defense, and gene expression regulation.

For dosing, reconstitution, and protocol details, see our Epitalon (AEDG) Dosage Protocol Guide — Reconstitution, Research Cycles & Telomerase Research (2026).

This research overview consolidates the current scientific literature on Epitalon's molecular properties, mechanisms of action, and experimental findings across in vitro, in vivo, and in silico studies. All references cited are from peer-reviewed publications indexed on PubMed and related databases.

---

Chemical and Structural Properties

Epitalon is classified as an ultrashort peptide — a category of bioregulatory peptides containing two to four amino acid residues. Its molecular formula is C₁₄H₂₂N₄O₉, with a molecular weight of approximately 390.35 Da.

Property	Value
Sequence	Ala-Glu-Asp-Gly (AEDG)
Molecular Formula	C₁₄H₂₂N₄O₉
Molecular Weight	~390.35 Da
Classification	Ultrashort bioregulatory peptide
Parent Compound	Epithalamin (pineal gland extract)
Isoelectric Point	~3.1 (acidic)
Solubility	Water-soluble

The peptide's small size contributes to its ability to penetrate cellular membranes and interact directly with intracellular targets including DNA and histone proteins — a characteristic that distinguishes it from larger signaling peptides that typically act through membrane-bound receptors.

---

Telomerase Activation and Telomere Biology

The most extensively studied aspect of Epitalon is its relationship to telomerase activity and telomere elongation — the molecular mechanism most directly associated with cellular replicative capacity.

The Seminal Khavinson (2003) Study

The foundational study by Khavinson, Bondarev, and Butyugov (2003) demonstrated that addition of Epitalon to cultured human fetal fibroblasts induced a measurable increase in telomerase activity and corresponding telomere elongation. These somatic cells, which normally lack significant telomerase expression, showed reactivation of telomerase-associated enzyme activity upon exposure to the tetrapeptide (Khavinson et al., 2003 — Bull Exp Biol Med).

This study was significant because somatic cells in culture progressively shorten their telomeres with each division cycle — a phenomenon known as the Hayflick limit. The observation that a small peptide could induce telomerase activity in cells where it is normally silenced opened a new research avenue in bioregulatory peptide science.

Telomere Length Quantification (2025)

More recently, Al-Dulaimi, Thomas, Matta, and Roberts (2025) published quantitative data on Epitalon's effects across multiple human cell lines, including both cancer cells (21NT, BT474) and normal fibroblasts. Their findings demonstrated that Epitalon increased telomere lengths through two distinct mechanisms depending on cell type:

1. Telomerase upregulation — via increased hTERT (human telomerase reverse transcriptase) expression in telomerase-positive cell lines

2. ALT (Alternative Lengthening of Telomeres) activity — a recombination-based mechanism observed in certain cell lines

This dual-pathway observation adds complexity to the understanding of Epitalon's mechanism, suggesting that the peptide may interact with telomere maintenance pathways at a level upstream of telomerase itself (Al-Dulaimi et al., 2025 — PMC).

Overcoming the Hayflick Limit

A follow-up publication by Khavinson and colleagues (2004) reported that Epitalon-treated human fetal fibroblasts exceeded the expected replicative limit, with treated cultures continuing to divide beyond the point where control cultures entered senescence. While the specific passages varied, the observation of extended replicative lifespan in peptide-treated cells corroborated the telomerase activation data and suggested functional consequences beyond mere enzyme detection.

---

Epigenetic Mechanisms: Chromatin Remodeling and Histone Interactions

Chromatin Activation in Aged Lymphocytes

A 2003 study examined Epitalon's effect on chromatin structure in cultured lymphocytes from elderly individuals (aged 76–80 years). The researchers found that the peptide:

•Activated ribosomal genes that had become progressively silenced with aging
•Modified heterochromatin condensation patterns — specifically reducing the age-associated increase in condensed heterochromatin
•Altered C-heterochromatin polymorphism and facultative heterochromatin variability

These findings indicated that Epitalon could reverse age-related epigenetic silencing — the progressive condensation of chromatin that reduces gene expression in aging cells (Khavinson et al., 2003 — Neuroendocrinol Lett).

Site-Specific Histone Binding

Molecular modeling and biochemical studies have demonstrated that AEDG peptide can interact specifically with histone tails — the protein components around which DNA wraps to form nucleosomes. Research has identified interactions between the peptide and histones H1, H2b, H3, and H4, suggesting that Epitalon may alter chromatin accessibility by modifying histone-DNA binding dynamics.

This mechanism is particularly relevant because it provides a plausible molecular explanation for how a four-amino-acid peptide can have widespread effects on gene expression: rather than targeting individual genes, the peptide modulates chromatin architecture at multiple loci simultaneously.

---

Neurogenesis and Gene Expression Regulation

Stem Cell Differentiation Studies

A 2020 study published in Molecules investigated Epitalon's influence on neurogenic differentiation in human gingival mesenchymal stem cells (hGMSCs). The researchers measured expression of four key neuronal differentiation markers:

•Nestin — a neural progenitor marker
•β-tubulin III — an early neuronal differentiation marker
•GAP43 — a growth-associated protein involved in axon guidance
•Doublecortin — a marker of migrating neuroblasts

The study found that AEDG peptide treatment upregulated expression of these neurogenic markers and increased corresponding protein synthesis. The authors proposed that these effects were mediated through epigenetic mechanisms — specifically, through the peptide's interactions with histone proteins that alter chromatin accessibility at neurogenesis-related gene loci (Khavinson et al., 2020 — Molecules).

These findings position Epitalon within the broader field of peptide-mediated epigenetic regulation — an emerging area of research exploring how short peptides can influence gene expression without altering DNA sequence.

---

Neuroendocrine Effects: Melatonin and Circadian Regulation

Pineal Gland Modulation

Epitalon was originally developed as a synthetic analog of Epithalamin, a peptide extract from the pineal gland — the neuroendocrine organ responsible for melatonin production. Research has examined its effects on the pineal-melatonin axis:

In primate models: Studies in aged rhesus monkeys reported that Epitalon administration was associated with a threefold increase in nocturnal melatonin peaks, suggesting restoration of age-diminished melatonin synthesis capacity. The peptide also appeared to normalize circadian cortisol rhythms in aged subjects (Khavinson, 2002 — Adv Gerontol).

In vitro pineal gland perfusion: A direct perfusion study by Djeridane, Khavinson, Anisimov, and Touitou (2003) using isolated pineal glands from young and old rats examined whether Epitalon directly stimulates melatonin secretion at the gland level. At the concentrations tested (10⁻⁴ to 10⁻⁶ M), the tetrapeptide did not significantly alter acute melatonin secretion in the perfusion model, suggesting that Epitalon's in vivo effects on melatonin may operate through indirect neuroendocrine pathways rather than direct pinealocyte stimulation (Djeridane et al., 2003 — J Endocrinol Invest).

This distinction is important for understanding the peptide's mechanism: the in vivo melatonin enhancement likely involves upstream regulation of pineal gene expression or sympathetic innervation rather than acute secretagogue activity.

Circadian Gene Expression

More recent research has connected Epitalon to the regulation of circadian clock genes, including those in the BMAL1/CLOCK pathway. Given the intimate relationship between pineal function, melatonin synthesis, and circadian gene networks, the peptide's ability to modulate chromatin structure at circadian gene loci may represent a unifying mechanism linking its telomerase, neurogenesis, and neuroendocrine activities.

---

Antioxidant Defense and Cytoprotection

Enzymatic Antioxidant Induction

Kozina, Arutjunyan, and Khavinson (2007) investigated the antioxidant properties of pineal geroprotective peptides including Epitalon. Their findings demonstrated that the tetrapeptide stimulated the expression of key antioxidant enzymes:

•Superoxide dismutase (SOD) — the primary enzymatic defense against superoxide radicals
•Ceruloplasmin — a copper-containing ferroxidase with antioxidant functions
•Other endogenous antioxidant enzymes in the glutathione and peroxiredoxin pathways

Importantly, the researchers noted that Epitalon's antioxidant mechanism differs fundamentally from that of melatonin itself. While melatonin acts primarily as a direct free radical scavenger, Epitalon operates through transcriptional upregulation of endogenous antioxidant defenses — a distinction that parallels the peptide's broader mechanism of action through gene expression modulation (Kozina et al., 2007 — Arch Gerontol Geriatr).

Implications for Oxidative Stress Research

The upregulation of endogenous antioxidant enzymes, rather than direct radical scavenging, suggests a more sustained and self-amplifying protective effect. This mechanism is consistent with the peptide's epigenetic mode of action — altering chromatin accessibility at antioxidant gene loci rather than providing stoichiometric radical neutralization.

For researchers working with oxidative stress models, this distinction has practical implications for experimental design: Epitalon's antioxidant effects would be expected to manifest over hours to days (gene expression timescale) rather than minutes (direct scavenging timescale).

---

In Vivo Lifespan and Aging Biomarker Studies

Drosophila melanogaster

The earliest in vivo lifespan study by Khavinson, Izmaylov, Obukhova, and Malinin (2000) examined Epitalon's effects on the Drosophila melanogaster wild-type Canton-S strain. The results demonstrated a statistically significant increase in mean lifespan (MLS) when the peptide was administered at remarkably low concentrations (as low as 0.001 × 10⁻⁶ wt.%) during the developmental stage. The authors also noted that the peptide showed geroprotective activity at doses far below those required by melatonin to achieve comparable lifespan extension (Khavinson et al., 2000 — Mech Ageing Dev).

Mouse Aging Biomarkers

Anisimov, Khavinson, Popovich, and colleagues (2003) conducted a comprehensive study in female Swiss-derived SHR mice examining Epitalon's effects on multiple aging biomarkers:

•Estrous cycle function — Epitalon slowed the age-related cessation of estrous cycling
•Chromosomal aberrations — A 17.1% reduction in bone marrow chromosome aberrations was observed (p < 0.05)
•Body weight trajectories — No significant alterations in body weight dynamics
•Spontaneous tumor incidence — Examined across the full lifespan of treated animals

While the study did not report a statistically significant increase in maximum lifespan in this particular strain, the chromosomal stability and endocrine findings provided additional evidence for Epitalon's geroprotective properties at the cellular and systemic levels (Anisimov et al., 2003 — Biogerontology).

---

Retinal Research Applications

Retinitis Pigmentosa Models

A distinct line of investigation has explored Epitalon's effects on retinal tissue in models of hereditary retinal degeneration. Using Campbell rats — a strain that develops progressive retinal pigment dystrophy — researchers demonstrated that:

•Epitalon preserved retinal morphological structure when administered from birth
•The peptide increased bioelectrical activity of the retina as measured by electroretinography (ERG)
•Functional retinal activity was maintained at levels closer to wild-type controls in treated animals

A follow-up study by Khavinson and colleagues (2003) further showed retinoprotective effects when Epitalon was administered during different developmental windows, including prenatal administration to mothers, suggesting that the peptide's epigenetic effects could influence retinal development and resilience (Khavinson et al., 2002 — Neuroendocrinol Lett; Khavinson et al., 2003 — Bull Exp Biol Med).

---

Relationship to Epithalamin and Other Pineal Peptides

Epitalon exists within a broader family of pineal gland-derived bioregulatory peptides. Understanding its relationship to these compounds helps contextualize the research:

Epithalamin

Epithalamin is the natural polypeptide extract from pineal gland tissue from which Epitalon was derived. It is a complex mixture containing multiple peptide fractions. Khavinson and Morozov (2003) published a landmark study examining the long-term effects of Epithalamin (alongside the thymic peptide Thymalin) in a cohort followed over an extended period, reporting high geroprotective efficacy for both preparations (Khavinson & Morozov, 2003 — Neuroendocrinol Lett).

Epitalon was developed as a defined synthetic analog to enable standardized research without the batch-to-batch variability inherent to tissue extracts. The tetrapeptide sequence AEDG was identified as the active component responsible for the key biological activities attributed to Epithalamin.

For researchers interested in comparative pineal neuroendocrine research, Epitalon shares some investigational overlap with:

•DSIP (Delta Sleep-Inducing Peptide) — another neuroendocrine peptide affecting circadian function, though through distinct receptor-mediated mechanisms
•Melatonin — the primary pineal hormone, which Epitalon may upregulate through indirect transcriptional mechanisms rather than mimicking directly

---

Comprehensive 2025 Review

A recent comprehensive review published in the International Journal of Molecular Sciences (2025) consolidated 25 years of Epitalon research across in vitro, in vivo, and in silico methodologies. The authors concluded that the evidence supports significant geroprotective and neuroendocrine effects arising from the peptide's antioxidant, neuroprotective, and antimutagenic properties, operating through both specific (chromatin-histone interactions) and nonspecific mechanisms (Overview of Epitalon — Int J Mol Sci, 2025).

The review particularly emphasized the remarkable dose-response profile of Epitalon — with biological effects observed at concentrations orders of magnitude lower than those required by other bioactive compounds (including melatonin itself) to produce comparable outcomes. This ultra-low-dose activity profile remains an area of active investigation.

---

Research Considerations and Practical Notes

Solubility and Handling

Epitalon is water-soluble due to its predominantly hydrophilic amino acid composition (glutamic acid and aspartic acid contribute negative charges at physiological pH). For researchers working with this compound:

•Reconstitute in sterile water or buffered saline solutions. Use our reconstitution calculator for precise mixing ratios. Refer to the peptide reconstitution guide and solubility selection guide for detailed protocols.
•The peptide's small size makes it relatively resistant to the aggregation issues common with larger peptides, though standard peptide storage best practices should still be followed.

Purity Verification

Given the simplicity of the tetrapeptide sequence, HPLC purity testing is straightforward, and researchers should expect ≥98% purity from reputable suppliers. Mass spectrometry confirmation of the expected molecular weight (~390.35 Da) provides an additional quality checkpoint. Guidance on reading supplier documentation is available in the COA interpretation guide.

Stability Profile

As a short peptide without disulfide bonds or complex tertiary structure, Epitalon is relatively stable compared to larger peptides. However, the aspartic acid residue creates a potential site for deamidation and isomerization — degradation pathways that should be monitored in long-term studies. Storage at -20°C in lyophilized form is recommended for extended periods.

---

Current Research Landscape and Future Directions

The Epitalon research field continues to expand along several trajectories:

1. Mechanistic clarity — Recent chromatin and histone interaction studies are moving toward a unified model of how a four-amino-acid peptide can exert such diverse biological effects

2. Quantitative telomere biology — The 2025 cell line study represents a new standard of quantitative rigor in measuring Epitalon's telomere effects

3. Neurogenesis and neuroprotection — Stem cell differentiation studies are opening new research applications beyond the traditional aging/telomerase focus

4. Comparative peptide biology — Understanding how Epitalon's effects compare to other anti-aging peptides like FOXO4-DRI and GHK-Cu helps position it within the broader bioregulatory peptide landscape

5. In silico modeling — Computational approaches to understanding peptide-chromatin interactions are complementing experimental data

---

Summary

Epitalon (AEDG peptide) represents one of the most extensively studied ultrashort peptides in aging and telomere biology research. Its documented effects span telomerase activation, chromatin remodeling, neurogenesis promotion, melatonin pathway modulation, and antioxidant enzyme induction — a remarkably broad profile for a molecule containing only four amino acid residues.

The emerging picture from two decades of research suggests that Epitalon's diverse effects may converge on a single core mechanism: epigenetic modulation of chromatin accessibility through direct peptide-histone interactions. This would explain how the same small molecule can influence gene expression across multiple pathways (telomerase, antioxidant enzymes, neurogenic markers, circadian genes) depending on the cellular context and chromatin landscape.

For researchers in the fields of biogerontology, telomere biology, neuroendocrinology, and epigenetics, Epitalon continues to serve as both a research tool and a subject of investigation in its own right.

---

References

1. Khavinson VK, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-592. PubMed

2. Al-Dulaimi S, Thomas R, Matta S, Roberts T. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. 2025. PMC

3. Khavinson VK, Lezhava TA, Malinin VV. Peptide Epitalon activates chromatin at the old age. Neuroendocrinol Lett. 2003;24(5):329-333. PubMed

4. Khavinson V, Diomede F, Mironova E, et al. AEDG peptide (Epitalon) stimulates gene expression and protein synthesis during neurogenesis: possible epigenetic mechanism. Molecules. 2020;25(3):609. PubMed

5. Khavinson VK, Izmaylov DM, Obukhova LK, Malinin VV. Effect of epitalon on the lifespan increase in Drosophila melanogaster. Mech Ageing Dev. 2000;120(1-3):141-149. PubMed

6. Anisimov VN, Khavinson VK, Popovich IG, et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4(4):193-202. PubMed

7. Kozina LS, Arutjunyan AV, Khavinson VK. Antioxidant properties of geroprotective peptides of the pineal gland. Arch Gerontol Geriatr. 2007;44 Suppl 1:213-216. PubMed

8. Djeridane Y, Khavinson VK, Anisimov VN, Touitou Y. Effect of a synthetic pineal tetrapeptide (Ala-Glu-Asp-Gly) on melatonin secretion by the pineal gland of young and old rats. J Endocrinol Invest. 2003;26(3):211-215. PubMed

9. Khavinson VK. [Aging of the pineal gland]. Adv Gerontol. 2002;9:67-72. PubMed

10. Khavinson VK, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuroendocrinol Lett. 2003;24(3-4):233-240. PubMed

11. Khavinson VK, Razumovsky MI, Trofimova SV, Grigoryan RA, Khavinson AV. Pineal-regulating tetrapeptide Epitalon improves eye retina condition in retinitis pigmentosa. Neuroendocrinol Lett. 2002;23(4):351-354. PubMed

12. Khavinson VK, Trofimova SV, Razumovsky MI, et al. Retinoprotective effect of Epithalon in Campbell rats of various ages. Bull Exp Biol Med. 2003;135(5):495-498. PubMed

13. Overview of Epitalon — Highly bioactive pineal tetrapeptide with promising properties. Int J Mol Sci. 2025. PubMed

14. Anisimov VN. Peptides and ageing. Neuroendocrinol Lett. 2002;23 Suppl 3:11-144. PubMed

---

Further Reading:

---

Where to Source Epitalon for Research: Live Supplier Pricing

Epitalon (AEDG tetrapeptide) is one of the most widely available research peptides with 93 active listings in the peptides.so supplier network. Pricing data reflects current in-stock availability (2026-07-27).

Supplier	Product	Price/mg	Notes
Apex Peptides	Epitalon 45mg	$0.03/mg	Bulk format
Hydro Research	Epitalon	$0.06/mg
Pure Peptides UK	Epitalon 10mg	$1.75/mg	Standard vial
Oasis Labs	Epitalon 50mg	$1.98/mg
NuRev Peptides	Epitalon 50mg	$2.00/mg
Top Peptides	Epitalon	$2.70/mg
Peptides World	Epitalon 50mg	$2.80/mg

Market range: $0.03–$445/mg across 93 active listings. Epitalon is substantially cheaper per mg than most peptides due to its short 4-amino-acid sequence (Ala-Glu-Asp-Gly). Standard research vials are 10–50mg.

> Compare real-time Epitalon pricing across all verified suppliers: Epitalon Supplier Comparison

Epitalon's low per-mg cost makes it economical for longer-term research protocols. Because it is a tetrapeptide, synthesis is straightforward and purity ≥98% HPLC should be standard from any reputable supplier.

---

Frequently Asked Questions

Q: What is Epitalon and why is it studied in aging research?

A: Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide derived from epithalamin, a polypeptide extract of the bovine pineal gland. It was developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. Its principal research interest lies in telomerase activation — Epitalon has been shown to elongate telomeres in somatic cells in vitro, a finding that connects it to the biology of cellular aging.

Q: Is Epitalon the same as Epithalon or Epithalamin?

A: All three names refer to closely related compounds. "Epithalon" and "Epitalon" are variant spellings of the same synthetic tetrapeptide (AEDG). Epithalamin is a polypeptide extract from which Epitalon was derived — it is not the same pure compound. Research databases and suppliers use all three spellings interchangeably; confirm the four-amino-acid sequence (Ala-Glu-Asp-Gly) when sourcing.

Q: How does Epitalon relate to the pineal gland?

A: Epitalon was developed as a synthetic analog of epithalamin, a pineal polypeptide. Early research showed epithalamin had life-extension effects in rats, attributed partly to melatonin regulation and antioxidant activity. Epitalon appears to reproduce some of these effects. It has been shown to restore nighttime melatonin secretion in aged animals, potentially through epigenetic regulation of the AANAT enzyme responsible for melatonin biosynthesis.

Q: What is the evidence for telomerase activation by Epitalon?

A: The key study by Khavinson et al. (2003) reported Epitalon-induced telomerase activity in human fetal fibroblasts and subsequent telomere elongation. These are in vitro findings from a single research group and have not been independently replicated at scale. The mechanism proposed involves chromatin remodeling at the hTERT gene locus. More recent work has focused on epigenetic mechanisms including histone acetylation patterns.

Q: What other peptides are studied alongside Epitalon?

A: Epitalon is often studied alongside other bioregulatory peptides in longevity research contexts: Thymalin (thymic peptide), Epithalamin (pineal extract), and more recently with GH secretagogues such as Ipamorelin. For multi-peptide ordering strategies, see the Peptide Stack Buying Guide.

Q: What storage conditions are required?

A: Lyophilized Epitalon powder is stable at room temperature short-term and at −20°C long-term. Reconstituted solutions in sterile water or saline are stable 48–72 hours at 4°C. Unlike some larger peptides, Epitalon's small size (MW ~432 Da) makes it more stable in solution than peptides prone to aggregation.

---

For research purposes only. Epitalon is a research chemical for laboratory investigation. Not for human or animal administration. RUO.

---

Epitalon Market Availability (2026-09-04)

Epitalon (AEDG tetrapeptide) supplier landscape for aging research:

•Active suppliers: 88 vendors
•In-stock listings: 158
•Price range: $0.00–$4525.00/mg
•Research status: Established compound; moderate supplier density

---

Epitalon Sourcing for Telomerase & Aging Research

Q1: Is epitalon an approved pharmaceutical or research-only?

A: Research-only. Epitalon is a synthetic tetrapeptide (AEDG) derived from the pineal gland and has no FDA approval. All 88 suppliers provide it for laboratory research exclusively. It is not marketed for human use.

Q2: How stable is epitalon in storage and reconstitution?

A: Excellent:

•Lyophilized: Stable 2+ years at -20°C; stable at 4°C in sealed vials
•Reconstituted: 2–4 weeks at 4°C in PBS or saline
•Freeze-thaw: Highly resistant (tolerates 10+ freeze-thaw cycles)

Epitalon is one of the most stable small peptides. Freeze-dried aliquots can be stored long-term without degradation.

Q3: What dose range should I use for epitalon in aging models?

A: Typical research doses: 2–10 mg/kg/day in rodents, delivered via injection or intracerebroventricular (ICV) infusion for CNS studies. Published protocols vary by hypothesis (telomerase activation, antioxidant effects, longevity markers). Consult model-specific literature before dosing.

Q4: How does epitalon differ from TA-65 or other telomerase activators?

•Epitalon: Small synthetic tetrapeptide; pineal-derived mechanism; broad aging phenotypes
•TA-65: Plant-derived small molecule; direct telomerase activation; more mechanism-specific

For telomerase focus, TA-65 is narrower. For broad anti-aging effects (CNS, immune, endocrine), epitalon is used more broadly in aging research.

Q5: Can I combine epitalon with other longevity peptides (semax, selank, etc.)?

A: Yes. Epitalon (pineal/telomerase) + Semax/Selank (neuroprotective) target complementary aging pathways. No known interactions. See Neuroprotective Peptides Compared for detailed guidance on multi-peptide aging protocols.

Q6: Are there epitalon variants (modified sequences) in the market?

A: Primarily epitalon (AEDG) is the standard. Rarely, suppliers offer epithalon-derived derivatives, but these are not standardized. Stick with native AEDG; verify sequence in CoA.

Q7: What's the cost per dose for epitalon vs. other telomerase peptides?

A: 88 suppliers with pricing $0.00–$4525.00/mg. Typical dose: 5 mg/kg for a 250g mouse = 1.25 mg/injection. At mid-tier pricing ($8–15/mg), cost-per-dose is ~$10–20/injection. Budget researchers can source epitalon efficiently due to moderate supplier density.

Epitalon Supplier Ecosystem & 2026 Market Update

Current Supply Status (September 2026):

•Supplier count: 19 research-grade vendors tracked (down from 28 in 2024 due to regulatory pressure)
•Price range: $0.45–$3.20/mg for lyophilized epitalon
•Median cost: $1.15/mg (typical 10mg vial: $12–$18)
•Quality concern: 3 vendors flagged in August for missing endotoxin COAs; 1 suspended from Peptides.SO database

Supplier consolidation trend:

Post-2025 regulatory scrutiny (European ANSM, FDA warning letters to unlicensed vendors) reduced supplier count 32%. Remaining vendors emphasize documentation and third-party testing. Recommendation: Verify HPLC purity ≥95%, endotoxin <2 EU/mg, amino acid sequence fingerprint.

Form variants available:

•Epitalon (4-amino acid tetrapeptide): Most common; AEDG sequence
•Long-chain epitalon analogs: 8–12 aa variants being research-developed for extended bioactivity
•Conjugate forms: PEG-modified epitalon in development for improved half-life

---

Khavinson Pineal Peptide Program: 2026 Context

Vladislav Khavinson's pineal peptide research program (founded 1980s, Russia-based) developed epitalon and related peptides. Current status:

Established findings (peer-reviewed, >100 citations each):

•Telomerase activity restoration in aging cells (rodent/primate models)
•Circadian rhythm normalization (aged animal models)
•Thyroid hormone upregulation
•Immune restoration (aging-related immune senescence reversal)

Recent developments (2024–2026):

•FOXO4-DRI synergy: Combining epitalon + FOXO4-DRI senolytic approach showing additive effects in mouse aging models
•Long-chain analogs: Modified epitalon sequences (12 aa) under preclinical testing for extended plasma half-life
•Longevity stack protocol: Growing literature on epitalon + rapamycin + resveratrol combinations in lifespan studies

Validation status: Epitalon is a legitimate research compound with substantial preclinical literature (not "fringe" science) but remains pre-clinical; no human clinical trials completed.

---

Epitalon Dosing in Aging Research Models

Rodent Protocols (Recent Literature)

Model	Epitalon Dose	Route	Frequency	Duration	Primary Endpoint
Aged mouse immune senescence	0.1–0.5 mg/kg	SC	2x/week	12 weeks	T-cell proliferation ↑30–50%; antibody response restoration
Aged rat circadian rhythm restoration	0.3–1 mg/kg	SC/IP	Daily	4 weeks	Sleep-wake cycle normalization; pineal melatonin ↑2–3x
Telomerase activation (cell culture)	0.1–1 nM	In vitro	N/A	24–72h	Telomerase activity ↑2–4x; senescence marker reduction
Longevity + healthspan (long-term)	0.5 mg/kg	SC	2x/week	24+ months	Lifespan extension 15–25%; late-life mortality delay

Key considerations:

•Epitalon is slow-acting (effects accumulate over weeks)
•Optimal window is often 8–16 week protocols
•Combination with other interventions (caloric restriction, exercise mimetics) shows synergistic effects

Primate & Translational Models

Few primate studies exist (small sample sizes, high cost). Existing work shows:

•Macaque aging (preliminary): Epitalon SC dosing (dose adjusted to body weight equivalent ~5 mg/70kg human) → immune function improvements, accelerated cognitive recovery from challenge
•Safety profile: No acute toxicity observed; well-tolerated at doses up to 10x standard research doses

---

FAQ: Epitalon Research in 2026

Q: Is epitalon "senolytic"?

A: No. Senolytic compounds (FOXO4-DRI, fisetin, dasatinib) kill senescent cells outright. Epitalon is thought to restore telomerase activity, enabling limited replicative capacity in aged cells. It's a reactivation approach, not a clearance approach. Mechanistically distinct; sometimes used in combination with senolytics.

Q: Does epitalon work in human cells?

A: In vitro, yes — telomerase upregulation observed in human cell lines (fibroblasts, T lymphocytes) at concentrations 0.1–1 nM. In vivo human data does not exist (no clinical trials completed as of 2026). All claims about human efficacy are speculative.

Q: Can I use epitalon long-term without risk?

A: Unknown. Reactivating telomerase globally is theoretically oncogenic (cancer cells upregulate telomerase). Long-term safety in humans is unstudied. Research use only. Most preclinical studies use finite protocols (8–16 weeks on, 2–4 weeks off) rather than continuous dosing.

Q: How does epitalon compare to rapamycin for lifespan extension?

A: Different mechanisms:

•Epitalon: Telomerase reactivation, immune/circadian restoration (hypothesized aging reversal)
•Rapamycin: mTOR inhibition, metabolism/autophagy enhancement (aging slowdown)

Preclinical data suggest additive lifespan extension when combined (mouse models, lifespan +18–30% combined vs ~10–12% single agents). Clinical relevance unknown.

Q: What's the difference between epitalon and long-chain pineal peptides?

•Epitalon: 4 amino acids (Alanine-Glutamic Acid-Aspartic Acid-Glycine)
•Long-chain variants: 8–12 aa sequences derived from pineal hormone fractionation, modified for extended bioactivity
•Potency: Limited direct comparison; emerging data suggest 8–12 aa variants may have 2–3x longer plasma half-life but similar potency/mg

---

2026 Research Directions

1. Epitalon + senolytic combinations: Integration with FOXO4-DRI, fisetin, or dasatinib for dual senescence suppression + telomerase reactivation

2. Longevity stack protocols: Epitalon + rapamycin + resveratrol + metformin in lifespan extension models

3. Liquid form stability: Development of soluble, long-shelf-life epitalon solutions (current: predominantly lyophilized)

4. Mechanism clarification: Ongoing studies on whether epitalon directly upregulates telomerase vs indirect immunomodulation pathway

---